A Montreal-based cancer therapeutics company focused on advancing several platform technologies that have potential to treat, diagnose and prevent cancer.
Development stage pharmaceutical company focused on the identification of cytochrome P450 enzymes for development of drug candidates and diagnostics. Located in Kingston, Ontario, Canada.
Provider of products and services that accelerate drug discovery and chemical development.
Privately-held Australian drug discovery company with a focus on inflammatory diseases such as: Asthma, Rheumatoid Arthritis, Allergic Rhinitis (Hay fever), Food allergy, Inflammatory Bowel Disease, inter alia. Cytopia's first molecular targets are members of the JAK family of protein tyrosine kinases.
UK company dedicated to the discovery of novel drug candidates in the anti-infective area.
Neurotech Pharmaceuticals, founded in Apr.1998, aims to develop and invent Novel lead compounds that will threaten diseases associated with brain disorders and mal-functional retardances.
Developing products that: 1) Protect humans against the debilitating side effects of cancer chemotherapy and radiotherapy, and 2) Protect animals and humans against lethal gastrointestinal pathogens and carcinogens.
Develops and commercializes innovative products for the treatment of serious pulmonary and infectious diseases and congenital disorders.
A high quality research, development and testing laboratories offering a broad range of services to all phases of the pharmaceutical industry from early drug development through commercial manufacturing.
An Asia-Pacific based, ICH-GCP compliant CRO offering a complete range of Clinical Research and New Drug Development Services.
|